Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004670133 | SCV005169489 | uncertain significance | not specified | 2024-03-18 | criteria provided, single submitter | clinical testing | The c.410G>A (p.S137N) alteration is located in exon 5 (coding exon 3) of the SLC16A12 gene. This alteration results from a G to A substitution at nucleotide position 410, causing the serine (S) at amino acid position 137 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005040740 | SCV005681142 | uncertain significance | Juvenile cataract-microcornea-renal glucosuria syndrome | 2024-04-26 | criteria provided, single submitter | clinical testing |